Skip to main content
TrimSoMoEverything GLP-1, in one place

Check where a number came from

Source register

The public sources behind facts on TrimSoMo. Open the original page to confirm the terms that apply to you.

CMS National Plan & Provider Enumeration System (NPPES)

Federal provider registry for obesity medicine directory. Filtered by taxonomy codes 207QB0002X, 207RB0002X, or 2080B0002X across any taxonomy position; non-U.S. locations and deactivated NPIs excluded. Inclusion does not indicate prescribing GLP-1 and is not an endorsement.

Source type
Federal Provider Registry
Data as of
Nov 2, 2026
Open CMS NPI Registry

FDA Inspections, Compliance & Warning Letters

Official regulatory warning letters database from the U.S. Food and Drug Administration (CDER / CVM). Verified records concerning GLP-1 medications (semaglutide, tirzepatide) and compounding practices. Does not assess commercial credit or disruption risk.

Source type
Federal Regulatory Register
Data as of
Nov 5, 2026
Open FDA Warning Letters

Success by Sesame weight loss program page

Source type
provider
Last checked
Nov 4, 2026
Open original source

FDA-approved Wegovy prescribing information

Source type
regulator
Last checked
Nov 4, 2026
Open original source

FDA-approved Zepbound prescribing information

Source type
regulator
Last checked
Nov 4, 2026
Open original source

DailyMed: Wegovy (semaglutide) tablets 1.5 mg, 4 mg, 9 mg, 25 mg (NDA 218316)

Source type
regulator
Last checked
Nov 6, 2026
Open original source

Eli Lilly Prescribing Information: Foundayo (orforglipron) tablets

Source type
regulator
Last checked
Nov 6, 2026
Open original source

NovoCare Wegovy Online Pharmacy & Delivery page

Source type
manufacturer
Last checked
Nov 7, 2026
Open original source

WeightWatchers Med+ Wegovy Pill program page

Source type
provider
Last checked
Nov 7, 2026
Open original source

FDA Prescribing Information: Saxenda (liraglutide) injection

Source type
regulator
Last checked
Nov 8, 2026
Open original source